臨床外科74巻2号

2019年02月発行

特集 急性胆囊炎診療をマスターしよう

総論

急性胆囊炎診療ストラテジーの変化について

著者： 高田忠敬¹

所属機関： ¹帝京大学

ページ範囲：P.151 - P.157

文献概要

【ポイント】
◆TGの発祥：世界共通の急性胆囊炎の診断基準・重症度判定・治療指針は，International Consensus Meeting, Tokyoでの合意に基づいたTG07（2007年）に始まった．
◆改訂の必要は？：TG07, TG13, TG18においては，臨床の場からの批評的評価を受け，ビッグデータを基に，時代の要請にあるべく改訂された．
◆TG18のポイント：TG13までは，Grade Ⅲは手術適応にはならなかったが，TG18では厳しい条件をクリアし，高次施設では適応になった．

参考文献

1）急性胆道炎の診療ガイドライン作成出版委員会（編）：科学的根拠に基づく急性胆管炎・胆囊炎の診療ガイドライン第1版．医学図書出版，2005

2）Takada T, Kawarada Y, Nimura Y, et al：Background：Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 14：1-10, 2007

3）Sekimoto, M, Takada T, Kawarada Y, et al：Need for criteria for the diagnosis and severity assessment of acute cholangitis and cholecystitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：11-14, 2007

4）Kimura Y, Takada T, Kawarada Y, et al：Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：15-26, 2007

5）Miura F, Takada T, Kawarada Y, et al：Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：27-34, 2007

6）Tsuyuguchi T, Takada T, Kawarada Y, et al：Techniques of biliary drainage for acute cholangitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：35-45, 2007

7）Tsuyuguchi T, Takada T, Kawarada Y, et al：Techniques of biliary drainage for acute cholecystitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：46-51, 2007

8）Wada K, Takada T, Kawarada Y, et al：Diagnostic criteria and severity assessment of acute cholangitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：52-58, 2007

9）Tanaka A, Takada T, Kawarada Y, et al：Antimicrobial therapy for acute cholangitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：59-67, 2007

10）Nagino M, Takada T, Kawarada Y, et al：Methods and timing of biliary drainage for acute cholangitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：68-77, 2007

11）Hirota M, Takada T, Kawarada Y, et al：Diagnostic criteria and severity assessment of acute cholecystitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：78-82, 2007

12）Yoshida M, Takada T, Kawarada Y, et al：Antimicrobial therapy for acute cholecystitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：83-90, 2007

13）Yamashita Y, Takada T, Kawarada Y, et al：Surgical treatment of patients with acute cholecystitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：91-97, 2007

14）Yasuda H, Takada T, Kawarada Y, et al：Unusual cases of acute cholecystitis and cholangitis：Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：98-113, 2007

15）Mayumi, Takada T, Kawarada Y, et al：Results of the Tokyo Consensus Meeting Tokyo Guidelines. J Hepatobiliary Pancreat Sci 14：114-121, 2007

16）Takada T：Needling the liver：Time of Young Lion. J Hepatobiliary Pancreat Sci 14：122-126, 2007

17）Strasberg SM：Acute Calculous Cholecystitis. N Engl J Med 358：2804-2811, 2008

18）Takada T, Strasberg SM, Solomkin JS, et al：TG13：Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 20：1-7, 2013

19）Kimura Y, Takada T, Strasberg SM, et al：TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 20：8-23, 2013

20）Kiriyama S, Takada T, Strasberg SM, et al：TG13 guidelines for diagnosis and severity grading of acute cholangitis（with videos）J Hepatobiliary Pancreat Sci 20：24-34, 2013

21）Yokoe M, Takada T, Strasberg SM, et al：TG13 diagnostic criteria and severity grading of acute cholecystitis（with videos）. J Hepatobiliary Pancreat Sci 20：35-46, 2013

22）Miura F, Takada T, Strasberg SM, et al：TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 20：47-54, 2013

23）Okamoto K, Takada T, Strasberg SM, et al：TG13 management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 20：55-59, 2013

24）Gomi H, Solomkin JS, Takada T, et al：TG13 antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 20：60-70, 2013

25）Itoi T, Tsuyuguchi T, Takada T, et al：TG13 indications and techniques for biliary drainage in acute cholangitis（with videos）. J Hepatobiliary Pancreat Sci 20：71-80, 2013

26）Tsuyuguchi T, Itoi T, Takada T, et al：TG13 indications and techniques for gallbladder drainage in acute cholecystitis（with videos）. J Hepatobiliary Pancreat Sci 20：81-88, 2013

27）Yamashita Y, Takada T, Strasberg SM, et al：TG13 surgical management of acute cholecystitis. J Hepatobiliary Pancreat Sci 20：89-96, 2013

28）Higuchi R, Takada T, Strasberg SM, et al：TG13 miscellaneous etiology of cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 20：97-105, 2013

29）Takada T：How far have we progressed since the Tokyo Guidelines 2013? J Hepatobiliary Pancreat Sci 24：307-309, 2017

30）Gomi H, Takada T, Hwang TL, et al：Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitis. J Hepatobiliary Pancreat Sci 24：310-318, 2017

31）Yokoe M, Takada T, Hwang TL, et al：Descriptive review of acute cholecystitis：Japan-Taiwan collaborative epidemiological study. J Hepatobiliary Pancreat Sci 24：319-328, 2017

32）Kiriyama S, Takada T, Hwang TL, et al：Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis：an international multicenter observational study. J Hepatobiliary Pancreat Sci 24：329-337, 2017

33）Yokoe M, Takada T, Hwang TL, et al：Validation of TG13 severity grading in acute cholecystitis：Japan-Taiwan collaborative study for acute cholecystitis. J Hepatobiliary Pancreat Sci 24：338-345, 2017

34）Endo I, Takada T, Hwang TL, et al：Optimal treatment strategy for acute cholecystitis based on predictive factors：Japan-Taiwan multicenter cohort study. J Hepatobiliary Pancreat Sci 24：346-361, 2017

35）Itoi T, Takada T, Hwang TL, et al：Percutaneous and endoscopic gallbladder drainage for acute cholecystitis：international multicenter comparative study using propensity score-matched analysis. J Hepatobiliary Pancreat Sci 24：362-368, 2017

36）Takada T：Tokyo guidelines 2018：updated Tokyo Guidelines for the management of acute cholangitis/acute cholecystitis. J Hepatobiliary Pancreatic Sci 25：1-2, 2018

37）Gomi H, Solomkin JS, Schlossberg, et al：Tokyo Guidelines 2018：antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 25：3-16, 2018

38）Kiriyama S, Kozaka K, Takada T, et al：Tokyo Guidelines 2018：diagnostic criteria and severity grading of acute cholangitis（with videos）. J Hepatobiliary Pancreat Sci 25：17-30, 2018

39）Miura F, Okamoto K, Takada T, et al：Tokyo Guidelines 2018：initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci 25：31-40, 2018

40）Yokoe M, Hata J, Takada T, et al：Tokyo Guidelines 2018：diagnostic criteria and severity grading of acute cholecystitis（with videos）. J Hepatobiliary Pancreat Sci 25：41-54, 2018

41）Okamoto K, Suzuki K, Takada T, et al：Tokyo Guidelines 2018：flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci 25：55-72, 2018

42）Wakabayashi G, Iwashita Y, Hibi T, et al：Tokyo Guidelines 2018：surgical management of acute cholecystitis：safe steps in laparoscopic cholecystectomy for acute cholecystitis（with videos）. J Hepatobiliary Pancreat Sci 25：73-86, 2018

43）Mori Y, Itoi T, Baron TH, et al：Tokyo Guidelines 2018：management strategies for gallbladder drainage in patients with acute cholecystitis（with videos）. J Hepatobiliary Pancreat Sci 25：87-95, 2018

44）Mayumi T, Okamoto K, Takada T, et al：Tokyo Guidelines 2018：management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 25：96-100, 2018

45）Panni RZ, Strasberg SM：Preoperative predictors of conversion as indicators of local inflammation in acute cholecystitis：strategies for future studies to develop quantitative predictors. J Hepatobiliary Pancreat Sci 25：101-108, 2018

46）Mukai S, Itoi T, Baron TH, et al：Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. J Hepatobiliary Pancreat Sci 24：537-549, 2017

47）急性胆管炎・胆囊炎診療ガイドライン改訂出版委員会（編）：—TG13新基準掲載—急性胆管炎・胆囊炎診療ガイドライン2013．医学図書出版，2013

48）Iwashita Y, Ohyama T, Honda G, et al：What are the appropriate indicators of surgical difficulty during laparoscopic cholecystectomy? Results from a Japan-Korea-Taiwan multinational survey. J Hepatobiliary Pancreat Sci 23：533-547, 2016

49）Hibi T, Iwashita Y, Ohyama T, et al：The “right” way is not always popular：comparison of surgeons' perceptions during laparoscopic cholecystectomy for acute cholecystitis among experts from Japan, Korea and Taiwan. J Hepatobiliary Pancreat Sci 24：24-32, 2017

50）Iwashita Y, Hibi T, Ohyama T, et al：An opportunity in difficulty：Japan-Korea-Taiwan expert Delphi consensus on surgical difficulty during laparoscopic cholecystectomy. J Hepatobiliary Pancreat Sci 24：191-198, 2017

51）Iwashita Y, Hibi T, Ohyama T, et al：Delphi consensus on bile duct injuries during laparoscopic cholecystectomy：an evolutionary cul-de-sac or the birth pangs of a new technical framework? J Hepatobiliary Pancreat Sci 24：591-602, 2017

52）急性胆管炎・胆囊炎診療ガイドライン改訂出版委員会：—TG18新基準掲載—（第3版）急性胆管炎・胆囊炎診療ガイドライン2018

53）ASA PHYSICAL STATUS CLASSIFICATION SYSTEM. Last approved by the ASA House of Delegates on October 15, 2014〔https://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system〕

54）Charlson ME, Pompei P, Ales KL, et al：A new method of classifying prognostic comorbidity in longitudinal studies：development and validation. J Chronic Dis 40：373-383, 1987

55）Charlson M, Szatrowski TP, Peterson J, et al：Validation of a combined comorbidity index, J Clin Epidemiol 47：1245-1251, 1994